Emad Yanni

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Affordable Care Act

Randomized Controlled Trial

Cell Proliferation

Respiratory Tract

Top Venues

Human vaccines & immunotherapeutics

GSK vaccine

Brunel University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GSK vaccine Mar 11 2014

United States

Lead Epidemiologist :: Clinical R&D

Education History

Brunel University Dec 01 1995

United Kingdom

MSC :: Medical Anthropology

Publications

Ignacio Salamanca de la Cueva, Elisa Cinconze, Tamara Eckermann, Ugo Nwoji, Lode Godderis, Emily Lu, Xavier Martínez-Gómez, Huajun Wang, Emad Yanni
Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season. Drug safety 44 (12) (2021)
Amber Hsiao, Philip O Buck, Arnold Yee, John Hansen, Edwin M Lewis, Laurie L Aukes, Emad Yanni, Rafik Bekkat-Berkani, Anne E Schuind, Nicola P Klein
Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children. Human vaccines & immunotherapeutics 16 (8) (2020)
Ruprecht Schmidt-Ott, Daniel Molnar, Anastassia Anastassopoulou, Emad Yanni, Claudia Krumm, Rafik Bekkat-Berkani, Gaël Dos Santos, Philipp Henneke, Markus Knuf, Markus Schwehm, Martin Eichner
Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations. Human vaccines & immunotherapeutics 16 (4) (2019)